KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Equity Ratio (2017 - 2026)

Cardlytics filings provide 10 years of Equity Ratio readings, the most recent being 0.02 for Q1 2026.

  • Quarterly Equity Ratio fell 108.73% to 0.02 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.02 through Mar 2026, down 108.73% year-over-year, with the annual reading at 0.02 for FY2025, 112.78% down from the prior year.
  • Equity Ratio hit 0.02 in Q1 2026 for Cardlytics, up from 0.02 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.58 in Q1 2022 and bottomed at 0.02 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.27, with a median of 0.31 recorded in 2022.
  • The largest annual shift saw Equity Ratio increased 5.43% in 2024 before it tumbled 112.78% in 2025.
  • Cardlytics' Equity Ratio stood at 0.31 in 2022, then dropped by 23.31% to 0.23 in 2023, then decreased by 24.09% to 0.18 in 2024, then crashed by 112.78% to 0.02 in 2025, then soared by 33.43% to 0.02 in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Equity Ratio are 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025).